Fundación Grupo Efecto Positivo Opposition, Lenacapavir, (Ar109364 A1)
No Annotations
Alert me when there are new annotations for this document
4 similar patent oppositions
-
Fundación Grupo Efecto Positivo opposition, Molnupiravir (MK-4482), (AR12285A1)
Countries: Argentina Date: 2022
-
Fundación Grupo Efecto Positivo opposition, Tenofovir 300mg+ Emtricitabina 200mg (TDF+FTC), (n/a)
Countries: Argentina Date: 2015
-
Fundación Grupo Efecto Positivo opposition, Sofosbuvir, (WO/2008/121634)
Countries: Argentina Date: 2015
-
Fundación Grupo Efecto Positivo opposition, Remdesivir, (WO2016069826 (A1))
Countries: Argentina Date: 2020